ADC Therapeutics SA Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-04 10:06:02 ET ADCT

Published on 05/04/2026 at 10:06 am EDT

ADC Therapeutics SA reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported revenue was USD 20.85 million compared to USD 23.03 million a year ago. Net loss was USD 32.97 million compared to USD 38.6 million a year ago.

Basic loss per share from continuing operations was USD 0.21 compared to USD 0.36 a year ago. Diluted loss per share from continuing operations was USD 0.21 compared to USD 0.36 a year ago.